ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NPTX Neuropathix Inc (CE)

0.0003
0.00 (0.00%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Neuropathix Inc (CE) USOTC:NPTX OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0003 0.00 01:00:00

Amended Statement of Changes in Beneficial Ownership (4/a)

18/03/2021 10:57pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

KIKIS THOMAS EVANGELOS
2. Issuer Name and Ticker or Trading Symbol

NEUROPATHIX, INC. [ NPTX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Communication Officer
(Last)          (First)          (Middle)

3805 OLD EASTON ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

3/12/2021
(Street)

DOYLESTOWN, PA 18902
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

3/16/2021 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy) $0.13 3/12/2021  A   800000     (1)3/11/2031 (2)Common Stock 800000 $0 800000 D  

Explanation of Responses:
(1) 1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter.
(2) This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on March 16, 2021 is being filed to correct an administrative error, resulting in the incorrect expiration date being included for the options. As reflected in this Form 4/A, the correct expiration date for the options is March 11, 2031.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
KIKIS THOMAS EVANGELOS
3805 OLD EASTON ROAD
DOYLESTOWN, PA 18902
X
Chief Communication Officer

Signatures
/s/ Thomas E. Kikis3/18/2021
**Signature of Reporting PersonDate

1 Year Neuropathix (CE) Chart

1 Year Neuropathix (CE) Chart

1 Month Neuropathix (CE) Chart

1 Month Neuropathix (CE) Chart